Gilbert D M, Heery D M, Losson R, Chambon P, Lemoine Y
Laboratoire de Génétique Moléculaire des Eucaryotes, Unité 184 de Biologie Moléculaire et de Génie Génétique, Institut National de la Santé et de la Recherche Medicale, Strasbourg, France.
Mol Cell Biol. 1993 Jan;13(1):462-72. doi: 10.1128/mcb.13.1.462-472.1993.
We have constructed and characterized a flexible system for analyzing the phenomenon of squelching and estrogen receptor function in the yeast Saccharomyces cerevisiae. The A/B region of the human estrogen receptor was replaced with the transcriptional activating domain of VP16 and expressed in yeast cells from high-copy-number plasmids. Addition of hormone resulted in an immediate inhibition of expression (squelching) of a chromosomally integrated GAL1:lacZ reporter gene and the eventual arrest of cell growth (toxicity). In order to determine whether a relationship exists between toxicity and squelching, mutations were made in this chimeric receptor (VEO) and their effects on transcriptional activation, squelching, and toxicity were compared. A direct correlation was found between mutations in VEO that reduced VP16 transactivation ability in yeast cells and those that reduced both squelching and toxicity. Surprisingly, mutations in the DNA binding domain (DBD) of VEO dramatically reduced squelching and completely relieved toxicity, suggesting a role for the DBD in squelching and strengthening the correlation between squelching and toxicity. To demonstrate the utility of this system for carrying out genetic selection, a plasmid-based yeast genomic bank was screened for genes that can relieve the toxicity of VEO by means of an elevated copy number, resulting in the repeated cloning of an allele of the PDR1 (pleiotropic drug resistance) gene. We present evidence that mutations in PDR1 can modulate the intracellular availability of estradiol by the same mechanism that leads to multiple drug resistance in yeast cells. Taken together, our results provide evidence that cell growth arrest occurs when squelching exceeds a certain threshold and that strong squelching requires both a DBD and a transcriptional activating domain. Furthermore, we show that growth arrest can provide a useful phenotype for carrying out the genetic analysis of both squelching and estrogen receptor function in yeast cells.
我们构建并表征了一个灵活的系统,用于分析酿酒酵母中抑制现象和雌激素受体功能。人雌激素受体的A/B区域被VP16的转录激活结构域取代,并在高拷贝数质粒的酵母细胞中表达。添加激素会立即抑制染色体整合的GAL1:lacZ报告基因的表达(抑制),并最终导致细胞生长停滞(毒性)。为了确定毒性和抑制之间是否存在关系,对这种嵌合受体(VEO)进行了突变,并比较了它们对转录激活、抑制和毒性的影响。发现VEO中降低酵母细胞中VP16反式激活能力的突变与降低抑制和毒性的突变之间存在直接相关性。令人惊讶的是,VEO的DNA结合结构域(DBD)中的突变显著降低了抑制作用并完全消除了毒性,表明DBD在抑制中起作用,并加强了抑制与毒性之间的相关性。为了证明该系统用于进行遗传筛选的实用性,通过提高拷贝数筛选基于质粒的酵母基因组文库中可减轻VEO毒性的基因,从而重复克隆了PDR1(多药耐药)基因的一个等位基因。我们提供的证据表明,PDR1中的突变可通过导致酵母细胞多重耐药的相同机制调节雌二醇的细胞内可用性。综上所述,我们的结果提供了证据,即当抑制超过一定阈值时会发生细胞生长停滞,并且强烈的抑制需要DBD和转录激活结构域。此外,我们表明生长停滞可为酵母细胞中抑制和雌激素受体功能的遗传分析提供有用的表型。